Maiva Pharma

Maiva Pharma, established in 1996, specializes in the contract manufacturing of sterile injectables, serving large pharmaceutical companies in regulated markets such as North America, Europe, and Australia. The company operates a state-of-the-art facility in Hosur, Tamilnadu, India, which is approved by both the USFDA and EU GMP. Maiva Pharma's product offerings include sterile solutions in vials and ampoules, with plans to add lyophilization capabilities by March 2021. The company prides itself on its commitment to quality, compliance, and ethical business practices, ensuring that all products and processes meet stringent regulatory standards from development through to commercial supply. Maiva Pharma's business model revolves around long-term partnerships, providing end-to-end solutions from product development to commercial supply, thereby generating revenue through contract manufacturing agreements. The company has built a solid reputation for reliability and excellence, continuously improving its operational processes to meet the evolving needs of its clients. Key clients include large pharmaceutical companies looking for high-quality, sterile injectable solutions.

Keywords: Sterile injectables, contract manufacturing, USFDA, EU GMP, vials, ampoules, lyophilization, quality, compliance, ethical business.